𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Propenylamide and propenylsulfonamide cephalosporins as a novel class of anti-MRSA β-lactams

✍ Scribed by Jens Pohlmann; Natalya I. Vasilevich; Andrei I. Glushkov; Laurenz Kellenberger; Stuart Shapiro; Patrick Caspers; Malcolm G.P. Page; Franck Danel


Book ID
104004486
Publisher
Elsevier Science
Year
2010
Tongue
English
Weight
419 KB
Volume
20
Category
Article
ISSN
0960-894X

No coin nor oath required. For personal study only.

✦ Synopsis


Novel C(3) propenylamide and propenylsulfonamide cephalosporins have been synthesized and tested for their ability to inhibit the penicillin-binding protein 2' (PBP2') from Staphylococcus epidermidis and the growth of a panel of clinically relevant bacterial species, including methicillin-resistant Staphylococcus aureus (MRSA). The most potent compounds inhibited the growth of MRSA strains with minimum inhibitory concentrations (MIC) as low as 1 microg/mL. The structure-activity relationship revealed the potential for further optimization of this new cephalosporin class.


📜 SIMILAR VOLUMES